Three new studies show that two doses of the JYNNEOS vaccine are somewhere between 66% and 86% effective at preventing mpox among people at risk. The research was published on Thursday in the New England Journal of Medicine and the CDC's Morbidity and Mortality Weekly,
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,